Cantor Fitzgerald Comments on Humana Inc.’s FY2024 Earnings (NYSE:HUM)

Humana Inc. (NYSE:HUM) – Research analysts at Cantor Fitzgerald lowered their FY2024 earnings estimates for shares of Humana in a report released on Thursday, April 25th. Cantor Fitzgerald analyst S. James now anticipates that the insurance provider will post earnings per share of $16.04 for the year, down from their previous forecast of $16.07. Cantor Fitzgerald has a “Neutral” rating and a $360.00 price objective on the stock. The consensus estimate for Humana’s current full-year earnings is $16.07 per share.

Humana (NYSE:HUM) last posted its quarterly earnings results on Wednesday, April 24th. The insurance provider reported $7.23 earnings per share for the quarter, beating analysts’ consensus estimates of $6.12 by $1.11. Humana had a net margin of 1.82% and a return on equity of 17.76%. The company had revenue of $29.61 billion for the quarter, compared to the consensus estimate of $28.52 billion. During the same period last year, the company posted $9.38 EPS. The firm’s quarterly revenue was up 10.7% compared to the same quarter last year.

HUM has been the topic of a number of other reports. Wells Fargo & Company reduced their price target on shares of Humana from $413.00 to $350.00 and set an “overweight” rating on the stock in a research note on Monday, April 8th. The Goldman Sachs Group cut their target price on shares of Humana from $450.00 to $385.00 and set a “buy” rating on the stock in a research report on Wednesday, April 3rd. TheStreet downgraded shares of Humana from a “b” rating to a “c+” rating in a research report on Monday, January 8th. TD Cowen cut their target price on shares of Humana from $427.00 to $396.00 and set a “buy” rating on the stock in a research report on Tuesday, April 2nd. Finally, Mizuho cut their target price on shares of Humana from $550.00 to $400.00 and set a “buy” rating on the stock in a research report on Friday, January 26th. Eleven equities research analysts have rated the stock with a hold rating and nine have issued a buy rating to the company. According to MarketBeat.com, the company presently has an average rating of “Hold” and an average target price of $424.50.

Humana Trading Down 1.8 %

HUM opened at $305.90 on Friday. The company’s 50 day moving average is $327.77 and its 200-day moving average is $393.91. Humana has a 1-year low of $299.23 and a 1-year high of $541.21. The company has a current ratio of 1.67, a quick ratio of 1.59 and a debt-to-equity ratio of 0.77. The company has a market cap of $36.86 billion, a P/E ratio of 19.05, a PEG ratio of 1.82 and a beta of 0.45.

Institutional Trading of Humana

Several institutional investors have recently made changes to their positions in the company. Rakuten Securities Inc. purchased a new position in shares of Humana in the 4th quarter worth about $25,000. Gradient Investments LLC grew its position in Humana by 200.0% during the fourth quarter. Gradient Investments LLC now owns 60 shares of the insurance provider’s stock valued at $27,000 after acquiring an additional 40 shares during the last quarter. Cetera Trust Company N.A bought a new position in Humana during the fourth quarter valued at approximately $28,000. Private Wealth Management Group LLC purchased a new stake in shares of Humana during the fourth quarter valued at approximately $32,000. Finally, Nvwm LLC boosted its stake in shares of Humana by 41.0% during the third quarter. Nvwm LLC now owns 86 shares of the insurance provider’s stock valued at $42,000 after purchasing an additional 25 shares during the period. Institutional investors own 92.38% of the company’s stock.

Insider Activity

In other Humana news, Director Jorge S. Mesquita purchased 545 shares of the firm’s stock in a transaction on Tuesday, February 20th. The stock was acquired at an average price of $367.09 per share, for a total transaction of $200,064.05. Following the purchase, the director now owns 2,578 shares of the company’s stock, valued at approximately $946,358.02. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. 0.32% of the stock is currently owned by company insiders.

Humana Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, July 26th. Stockholders of record on Friday, June 28th will be paid a $0.885 dividend. The ex-dividend date is Friday, June 28th. This represents a $3.54 annualized dividend and a dividend yield of 1.16%. Humana’s dividend payout ratio is currently 22.04%.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.